Webinar: The ALS-Reproducible Antibody Platform (ALS-RAP)
GeneTex is honored to host Dr. Carl Laflamme, a senior postdoctoral research fellow in the laboratory of the distinguished Dr. Peter McPherson at McGill University’s Montreal Neurological Institute. Dr. Laflamme’s work has focused on understanding the mechanisms underlying amyotrophic lateral sclerosis (ALS) with particular emphasis on C9orf72, a gene whose disruption represents the most common genetic cause of ALS/frontotemporal dementia (FTD).
Online
In his talk, Dr. Laflamme will discuss his published work describing the systematic assessment of antibodies against the C9ORF72 protein as part of ALS-RAP. He will then present intriguing data regarding C9ORF72 biology in macrophages, and will introduce his very exciting and potentially revolutionary efforts to expand the ALS-RAP methodology for antibodies against additional ALS disease proteins as well as those of other neurodegenerative disorders. Dr. Laflamme will explain how this approach will be further broadened and amplified to address the commercial antibody reliability crisis in biomedical research.
When: Tuesday 8 June, 2021 17:00 Central European Time
Please contact us for the possibility to watch a recording.
Related images
